Malignant melanoma Antibody
Malignant melanoma Antibody
Melanoma Tissue Slide (Skin- Melanoma) |
|||
| 12-801-4um | ProSci | 4 um | 216.6 EUR |
Small Intestine Tissue Slide (Malignant) |
|||
| 11-814-10um | ProSci | 10 um | 241.8 EUR |
Small Intestine Tissue Slide (Malignant) |
|||
| 11-814-4um | ProSci | 4 um | 216.6 EUR |
Ovary Tissue Slide (Malignant Tumor) |
|||
| 11-206-10um | ProSci | 10 um | 241.8 EUR |
Ovary Tissue Slide (Malignant Tumor) |
|||
| 11-206-4um | ProSci | 4 um | 216.6 EUR |
Liver Tissue Slide (Malignant tumor) |
|||
| 10-220-10um | ProSci | 10 um | 241.8 EUR |
Liver Tissue Slide (Malignant tumor) |
|||
| 10-220-4um | ProSci | 4 um | 216.6 EUR |
Stomach Tissue Slide (Malignant Tumor) |
|||
| 10-807-10um | ProSci | 10 um | 241.8 EUR |
Stomach Tissue Slide (Malignant Tumor) |
|||
| 10-807-4um | ProSci | 4 um | 216.6 EUR |
Stomach Tissue Slide (Malignant Tumor) |
|||
| RF10002-05-10um | ProSci | 10 um | 241.8 EUR |
Stomach Tissue Slide (Malignant Tumor) |
|||
| RF10002-05-4um | ProSci | 4 um | 216.6 EUR |
Melanoma Marker(PNL2) Antibody |
|||
| BNCA0894-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), APC conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNCAP0894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNCAP0894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Inhibitory Activity Antibody |
|||
| DF14235 | Affbiotech | 100ul | 420 EUR |
Melanoma Marker(PNL2) Antibody |
|||
| BNC610894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC610894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNUM0894-50 | Biotium | 50uL | 474 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), 1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNCR0894-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), RPE conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNUB0894-100 | Biotium | 100uL | 250.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), Concentration: 0.2mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNUB0894-500 | Biotium | 500uL | 549.6 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), Concentration: 0.2mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC430894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC430894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC400894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC400894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC880894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC880894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC800894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC800894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC810894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC810894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNCH0894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNCH0894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNCP0894-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC050894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC050894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC680894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC680894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC700894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC700894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNCB0894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNCB0894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC940894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC940894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC550894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC550894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC470894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC470894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Melanoma associated antigen antibody |
|||
| 10R-M160a | Fitzgerald | 1 mL | 626.4 EUR |
|
Description: Mouse monoclonal Melanoma associated antigen antibody |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC040894-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Melanoma Marker(PNL2) Antibody |
|||
| BNC040894-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Melanoma Marker(PNL2), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Anti-Human Melanoma antibody |
|||
| STJ16100391 | St John's Laboratory | 1 mL | 835.2 EUR |
Anti-Melanoma Marker antibody |
|||
| STJ16100745 | St John's Laboratory | 1 mL | 422.4 EUR |
Melanoma Lysate |
|||
| 20-101 | ProSci | 0.1 mg | 632.4 EUR |
|
Description: Melanoma lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human melanoma tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the melanoma tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The melanoma tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
Human Malignant T cell amplified sequence 1 Antibody |
|||
| 33361-05111 | AssayPro | 150 ug | 313.2 EUR |
Deleted In Malignant Brain Tumors 1 (DMBT1) Antibody |
|||
| 20-abx172078 | Abbexa |
|
|
Malignant T-Cell Amplified Sequence 1 (MCTS1) Antibody |
|||
| abx145454-100ug | Abbexa | 100 ug | 469.2 EUR |
Malignant T-Cell Amplified Sequence 1 (MCTS1) Antibody |
|||
| 20-abx124616 | Abbexa |
|
|
Malignant T-Cell Amplified Sequence 1 (MCTS1) Antibody |
|||
| 20-abx339434 | Abbexa |
|
|
Malignant T-Cell Amplified Sequence 1 (MCTS1) Antibody |
|||
| 20-abx339553 | Abbexa |
|
|
Malignant T-Cell Amplified Sequence 1 (MCTS1) Antibody |
|||
| abx432953-200ul | Abbexa | 200 ul | 460.8 EUR |
Malignant T-Cell Amplified Sequence 1 (MCTS1) Antibody |
|||
| 20-abx301748 | Abbexa |
|
|
Deleted In Malignant Brain Tumors 1 (DMBT1) Antibody |
|||
| 20-abx176133 | Abbexa |
|
|
Deleted In Malignant Brain Tumors 1 (DMBT1) Antibody |
|||
| 20-abx213667 | Abbexa |
|
|
Malignant T-Cell Amplified Sequence 1 (MCTS1) Antibody |
|||
| abx235070-100ug | Abbexa | 100 ug | 577.2 EUR |
Bladder Tissue Slide (Malignant epithelial tumor) |
|||
| 12-610-10um | ProSci | 10 um | 241.8 EUR |
Bladder Tissue Slide (Malignant epithelial tumor) |
|||
| 12-610-4um | ProSci | 4 um | 216.6 EUR |
Bovine malignant catarrhal fever PCR kit |
|||
| PCR-V209-48D | Bioingentech | 50T | 543.6 EUR |
Bovine malignant catarrhal fever PCR kit |
|||
| PCR-V209-96D | Bioingentech | 100T | 686.4 EUR |
Melanoma Marker(KBA.62) Antibody |
|||
| BNCA0895-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against Melanoma Marker(KBA.62), APC conjugate, Concentration: 0.1mg/mL |
|||